Ginkgo Bioworks Holdings (DNA) — Technical state
As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +19.4% vs the 50-day and +35.4% vs the 200-day average, 36.1% below the 52-week high and +116.9% off the 52-week low; a golden cross printed 21 sessions ago. Computed from daily closes. (as of 2026-11-04)
- Trend: Ginkgo Bioworks Holdings trades 19.4% above its 50-day and 35.4% above its 200-day moving average. (as of 2026-11-04)
Ginkgo Bioworks builds a platform for engineering living cells, selling research services, lab tools and automation systems that other firms use to design organisms for medicines, crops, food and industrial materials. A separate arm, run through its Canopy and Horizon services, gathers genomic data and watches for biological threats for government and other clients.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the DNA overview. Research diary readings, not advice.
Trades +19.4% vs the 50-day and +35.4% vs the 200-day average, 36.1% below the 52-week high and +116.9% off the 52-week low; a golden cross printed 21 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+5%
- vs 50-day+19.4%
- vs 200-day+35.4%
- 52-week band36.1% off the high · +116.9% off the low
- Streak2 consecutive up sessions
- CrossoverGolden cross 21 sessions ago
- 50-day crossprice crossed up through the 50-day 34 sessions ago
- Stochastic%K 50.5 · %D 27.6 · bull cross
Continue: the DNA chart & overview · the signal board
FAQ · from the current data · as of 2026-11-04
Quick answers
What is the current Closelooknet signal on DNA?
Uptrend stack intact — Trades +19.4% vs the 50-day and +35.4% vs the 200-day average, 36.1% below the 52-week high and +116.9% off the 52-week low; a golden cross printed 21 sessions ago. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is DNA above its 50-day and 200-day moving averages?
As of 2026-11-04, Ginkgo Bioworks Holdings trades +19.4% above its 50-day and +35.4% above its 200-day average, with the 20-day +5% away.
How far is DNA from its 52-week high?
36.1% below the 52-week high and 116.9% above the 52-week low, as of 2026-11-04.
Mentioned on Closelooknet
Where DNA appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Long reads
- Value Investing — Tech-Free, a Flag of Inconvenience
A portfolio of high-quality slow-growers, dutifully rebalanced, is a portfolio with built-in underperformance DNA .
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry
- MRNA Moderna Incindustry
- XNCR Xencor Incindustry
- VRDN Viridian Therapeutics Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- KYMR Kymera Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- MEDCL.PA Medincell SAindustry
- LEGN Legend Biotech Corpindustry
- ORKA Oruka Therapeutics, Inc.industry